Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ascendis Pharma A (ASND) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Ascendis Pharma A (ASND) over the last 12 years, with Q4 2025 value amounting to $91.4 million.

  • Ascendis Pharma A's Net Cash Flow rose 19779.66% to $91.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $99.2 million, marking a year-over-year decrease of 3937.17%. This contributed to the annual value of $92.4 million for FY2025, which is 4022.13% down from last year.
  • According to the latest figures from Q4 2025, Ascendis Pharma A's Net Cash Flow is $91.4 million, which was up 19779.66% from $47.9 million recorded in Q3 2025.
  • In the past 5 years, Ascendis Pharma A's Net Cash Flow registered a high of $407.7 million during Q3 2024, and its lowest value of -$295.0 million during Q4 2021.
  • Over the past 5 years, Ascendis Pharma A's median Net Cash Flow value was -$56.5 million (recorded in 2023), while the average stood at -$345641.7.
  • Data for Ascendis Pharma A's Net Cash Flow shows a peak YoY increase of 81662.5% (in 2024) and a maximum YoY decrease of 22229.88% (in 2024) over the last 5 years.
  • Quarter analysis of 5 years shows Ascendis Pharma A's Net Cash Flow stood at -$295.0 million in 2021, then surged by 51.19% to -$144.0 million in 2022, then skyrocketed by 68.71% to -$45.1 million in 2023, then crashed by 107.47% to -$93.5 million in 2024, then skyrocketed by 197.8% to $91.4 million in 2025.
  • Its Net Cash Flow was $91.4 million in Q4 2025, compared to $47.9 million in Q3 2025 and -$5.3 million in Q2 2025.